Geode Capital Management, LLC Bio Xcel Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 311,965 shares of BTAI stock, worth $720,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
311,965
Previous 298,043
4.67%
Holding current value
$720,639
Previous $181,000
36.46%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding BTAI
# of Institutions
51Shares Held
8.69MCall Options Held
22.2KPut Options Held
27.7K-
Armistice Capital, LLC New York, NY4.32MShares$9.97 Million0.02% of portfolio
-
Ubs Group Ag1.28MShares$2.95 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.19MShares$2.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$1.02 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA199KShares$459,7130.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $64.7M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...